Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,524 | -1,926 | -10,210 | -7,766 | -5,723 |
| Depreciation Amortization | 79 | 40 | 160 | 124 | 83 |
| Accounts payable and accrued liabilities | -110 | 360 | -337 | 212 | 98 |
| Other Working Capital | 230 | 463 | 310 | 875 | 1,265 |
| Other Operating Activity | 6,670 | -146 | 97 | -624 | -785 |
| Operating Cash Flow | $-2,655 | $-1,209 | $-9,980 | $-7,179 | $-5,062 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | N/A | -50 | -53 | -53 |
| Other Investing Activity | 0 | 0 | -60 | 0 | 0 |
| Investing Cash Flow | $-6 | $N/A | $-110 | $-53 | $-53 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 500 | 500 | 500 | 500 | N/A |
| Debt Repayment | -19 | -12 | -117 | -106 | -46 |
| Other Financing Activity | 9,199 | 522 | 3,327 | 369 | -1,730 |
| Financing Cash Flow | $9,680 | $1,010 | $3,710 | $763 | $-1,776 |
| Beginning Cash Position | 503 | 503 | 6,890 | 6,891 | 6,891 |
| End Cash Position | 7,522 | 304 | 500 | 422 | N/A |
| Net Cash Flow | $7,019 | $-199 | $-6,380 | $-6,469 | $-6,891 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,655 | -1,209 | -9,980 | -7,179 | -5,062 |
| Capital Expenditure | -6 | N/A | -59 | -53 | -53 |
| Free Cash Flow | -2,661 | -1,209 | -10,039 | -7,232 | -5,115 |